What post‑exposure prophylaxis, including rabies vaccine schedule and tetanus protection, should be administered after a fox bite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Post-Exposure Prophylaxis After Fox Bite

For a previously unvaccinated person bitten by a fox, immediately initiate rabies post-exposure prophylaxis with thorough wound cleansing, rabies immune globulin (20 IU/kg infiltrated into/around wounds), and a 4-dose rabies vaccine series (days 0,3,7,14), plus ensure tetanus protection is current. 1

Immediate Wound Management

Begin with aggressive local wound care:

  • Cleanse thoroughly with soap and water for 15 minutes 1
  • Use a virucidal agent (povidone-iodine solution) if available 1
  • Perform cautious debridement of devitalized tissue only—avoid enlarging the wound 2
  • Do not suture the wound (infected wounds should remain open) 2

Rabies Risk Assessment

Foxes are high-risk rabies vectors and should be considered rabid unless proven otherwise. Wild carnivores like foxes warrant immediate rabies prophylaxis without waiting for animal testing results. The fox should be captured and tested if possible, but treatment should not be delayed.

Rabies Post-Exposure Prophylaxis Protocol

For Previously Unvaccinated Persons:

Human Rabies Immune Globulin (HRIG):

  • Administer 20 IU/kg body weight on day 0 1
  • Infiltrate the full dose into and around the wound(s) if anatomically feasible 1
  • Inject any remaining volume intramuscularly at a site distant from vaccine administration 1
  • Never administer HRIG in the same syringe or same anatomic site as the first vaccine dose 1
  • If HRIG was not given on day 0, it can still be administered up to and including day 7 of the series 1, 3
  • Do not exceed the recommended dose—excess HRIG can suppress active antibody production 1, 3

Rabies Vaccine:

  • Use either HDCV (human diploid cell vaccine) or PCECV (purified chick embryo cell vaccine) 1
  • Administer 4 doses of 1.0 mL intramuscularly on days 0,3,7, and 14 1
  • Deltoid area for adults and older children; anterolateral thigh acceptable for young children 1
  • Never use the gluteal area—results in diminished immune response 1
  • Day 0 is the day the first dose is administered (start as soon as possible) 1

For Previously Vaccinated Persons:

If the patient has documented prior rabies vaccination:

  • No HRIG 1
  • Only 2 vaccine doses: 1.0 mL IM on days 0 and 3 1
  • Still perform thorough wound cleansing 1

Special Populations:

Immunocompromised patients require a 5-dose vaccine regimen (days 0,3,7,14, and 28) instead of the standard 4-dose series 1

Tetanus Protection

Verify tetanus immunization status immediately:

  • If last tetanus toxoid was >5 years ago for contaminated wounds, or >10 years for clean wounds, administer 0.5 mL tetanus toxoid intramuscularly 2
  • If tetanus status is unknown or incomplete primary series, give tetanus toxoid 2
  • Administer at a different site than rabies vaccine

Critical Pitfalls to Avoid

  1. Never delay treatment waiting for animal testing—fox bites warrant immediate prophylaxis
  2. Do not skip HRIG in previously unvaccinated persons—it provides immediate passive immunity until active antibody production begins 1, 3
  3. Do not infiltrate HRIG and vaccine at the same site initially—can interfere with vaccine immunogenicity 1
  4. Do not use gluteal injection site—associated with vaccine failure 1
  5. Do not close/suture the wound—increases infection risk 2

Schedule Deviations

If doses are delayed by a few days, simply resume the schedule without restarting the series 3. For example, if the day 7 dose is given on day 10, continue with remaining doses maintaining the same intervals (days 17 and 31 in this example) 3.

Antibiotic Prophylaxis

Consider prophylactic antibiotics (amoxicillin-clavulanate preferred) for 3-5 days, particularly for:

  • Hand wounds
  • Deep puncture wounds
  • Wounds near bones or joints
  • Presentation >8 hours after injury 2

Follow-Up

  • Reassess within 24 hours (phone or office visit) 2
  • Monitor for signs of infection: increasing pain, erythema, purulent drainage, fever
  • Watch for complications: cellulitis, abscess, osteomyelitis, septic arthritis 2
  • If infection progresses despite treatment, hospitalize 2

The combination of proper wound care, HRIG, and the 4-dose vaccine series is highly effective—no treatment failures have been documented when this protocol is followed correctly in immunocompetent individuals. 1, 4

Related Questions

Does a patient who was accidentally struck on the face by a dog’s teeth without any skin break, and whose dog was vaccinated against rabies 6 months ago, require post‑exposure rabies vaccination?
After being bitten by a dog vaccinated against rabies last year (next dose due in two days) and currently healthy, do I need rabies post‑exposure prophylaxis, antibiotics for the wound, or a tetanus booster?
What is the four-dose rabies vaccine schedule for post-exposure prophylaxis in an unvaccinated person?
Is rabies post-exposure prophylaxis (PEP) needed after a dog scratch if the dog's rabies vaccination status is unknown or not up-to-date?
If the dog is documented to be vaccinated against rabies, what rabies post‑exposure prophylaxis should be given to the bite victim?
How does Humate‑P (plasma‑derived factor VIII/von Willebrand factor complex) differ from emicizumab and what are its indications for use?
Can an angiotensin receptor neprilysin inhibitor (ARNI) such as sacubitril/valsartan be used in a patient with unilateral renal artery stenosis?
What are the differences between conductive and sensorineural hearing loss?
Is work clearance appropriate for a patient with non‑alcoholic fatty liver disease and a normal alanine aminotransferase (ALT) level?
Is a patient with dyslipidemia who is asymptomatic, on stable lipid‑lowering therapy with recent acceptable lipid levels, eligible for work clearance without restrictions?
What are the causes of chronic diarrhea and what additional investigations should be performed beyond testing for bacterial, helminthic, and protozoal infections?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.